Atrás
Rango del Día
$1.81
$1.90
Rango de 52 Semanas
$0.62
$2.29
Volumen
9,000
Promedio 50D / 200D
$1.91
/
$1.58
Cierre Anterior
$1.81
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -6.4 | 0.3 |
| P/B | 1.0 | 2.9 |
| ROE % | -14.0 | 3.7 |
| Net Margin % | -23455.7 | 3.8 |
| Rev Growth 5Y % | -56.2 | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
-$0.37
-$0.37 – -$0.37
|
39 M | 1 |
| FY2026 |
$0.90
$0.90 – $0.90
|
1.3 B | 1 |
Puntos Clave
Revenue declined -56.24% annually over 5 years
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -343.73M
Revenue growth is decelerating — 1Y growth trails 5Y average by 41.49%
Capital intensive — 167.42% of revenue goes to capex
Crecimiento
Revenue Growth (5Y)
-56.24%
Revenue (1Y)-97.73%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-13.97%
ROIC-11.23%
Net Margin-23455.65%
Op. Margin-23025.64%
Seguridad
Debt / Equity
0.00
Current Ratio12.88
Interest Coverage0.00
Valoración
P/E Ratio
-6.35
P/B Ratio0.97
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -97.73% | Revenue Growth (3Y) | -84.60% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -56.24% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.28M | Net Income (TTM) | -300.94M |
| ROE | -13.97% | ROA | -14.16% |
| Gross Margin | 57.29% | Operating Margin | -23025.64% |
| Net Margin | -23455.65% | Free Cash Flow (TTM) | -343.73M |
| ROIC | -11.23% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 12.88 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -6.35 | P/B Ratio | 0.97 |
| P/S Ratio | 1488.83 | PEG Ratio | -0.04 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.91B | Enterprise Value | 1.05B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1.28M | 56.60M | 54.09M | 76.88M | 35.00M |
| Net Income | -300.94M | -144.72M | -314.84M | -199.02M | -209.24M |
| EPS (Diluted) | -0.30 | -0.13 | -0.29 | -0.18 | -0.20 |
| Gross Profit | 735,000.0 | 25.99M | -24.69M | 39.17M | -23.50M |
| Operating Income | -295.42M | -300.21M | -343.98M | -224.97M | -217.11M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 2.12B | 2.49B | 2.66B | 2.83B | 3.07B |
| Total Liabilities | 158.41M | 148.94M | 117.16M | 100.89M | 85.42M |
| Shareholders' Equity | 1.97B | 2.34B | 2.54B | 2.73B | 2.98B |
| Total Debt | 7.63M | 8.42M | 4.24M | 2.75M | 1.59M |
| Cash & Equivalents | 865.73M | 330.12M | 2.47B | 2.50B | 2.71B |
| Current Assets | 1.97B | 2.33B | 2.54B | 2.63B | 2.83B |
| Current Liabilities | 153.05M | 140.68M | 108.19M | 90.97M | 73.77M |